The SYNB BioRevolution ETF (SYNB) is an exchange-traded fund incorporated in the USA. This ETF aims to achieve long-term capital appreciation by primarily investing in common stocks of companies worldwide, irrespective of their size, with a strong focus on those harnessing innovations within the field of biology. SYNB actively manages a high-conviction portfolio that provides exposure to the bio revolution, encompassing advancements in biological and life sciences that are reshaping the global economy. The fund's investments span technology enablers facilitating biological production, disruptive biotech and synthetic biology firms, as well as other companies poised to benefit from this transformative theme. SYNB's portfolio predominantly consists of growth stocks, and the fund manager employs a comprehensive approach when selecting investments, considering factors like valuation, financial strength, growth potential, industry position, projected earnings, cash flows, and dividends.
The Putnam BioRevolution ETF (SYNB) focuses on long-term capital appreciation through investments in companies worldwide that leverage innovations within the field of biology. While the primary objective is capital appreciation, SYNB reflects the dividend distribution of its constituent companies. Dividends are typically influenced by the individual dividend policies and performances of these companies. SYNB's portfolio primarily consists of growth stocks, and the fund manager considers various factors, including dividends, when selecting stocks. Investors in SYNB may benefit from potential dividend returns alongside the pursuit of innovative growth opportunities in the biological sciences sector.
The SYNB ETF, known as the Putnam BioRevolution ETF, is designed to closely follow the performance of companies driving biological innovation worldwide. This ETF primarily invests in businesses of all sizes that contribute to the bio revolution, including technology enablers supporting biological production, disruptive biotech and synthetic bio firms, and other companies positioned to benefit from this transformative theme. Beyond healthcare, SYNB also has exposure to sectors like consumer discretionary, consumer staples, materials, and agriculture, making it a comprehensive choice for investors seeking to align their portfolios with the advancements in the biological and life sciences. SYNB's portfolio predominantly consists of growth stocks, with careful consideration of various factors, including valuation, financial strength, growth potential, industry position, future earnings, cash flows, and dividends, when selecting its holdings.
The correlation aspect of the Putnam BioRevolution ETF (SYNB) is crucial for investors seeking to understand its behavior in relation to the broader equity market. Given SYNB's focus on companies leveraging biological innovation, its correlation with the biotech sector and related industries can be significant. To gain deeper insights into SYNB's correlations with specific sectors and assets, investors can utilize ETF Insider's web app, which offers comprehensive data visualization tools. This valuable resource allows investors to assess SYNB's overlap with other ETFs, aiding in making informed investment decisions within the biotech and innovative biology space.
The SYNBiotech Revolution ETF (SYNB) is heavily focused on the biotechnology sector. This ETF primarily invests in companies worldwide that are at the forefront of biological innovation. SYNB's portfolio encompasses a wide range of companies, including technology enablers supporting biological production, disruptive biotech and synthetic bio firms, and other businesses poised to benefit from the bio revolution. While the ETF's core exposure is within the healthcare sector, it also explores opportunities in consumer discretionary, consumer staples, materials, and agriculture sectors that are likely to experience positive impacts from advancements in biological and life sciences. SYNB's investment strategy mainly centers on growth stocks, considering factors such as valuation, financial strength, growth potential, industry position, projected earnings, cash flows, and dividends.
The exposure characteristics of the Putnam BioRevolution ETF (SYNB) focus on companies worldwide that leverage innovation within biology. This ETF actively invests in firms of all sizes that contribute to the bio revolution, which encompasses technological advancements in the biological and life sciences. SYNB''s portfolio includes technology enablers, disruptive biotech or synthetic bio companies, and other firms positioned to benefit from this theme. While healthcare is a significant part of its exposure, SYNB may also invest in sectors like consumer discretionary, consumer staples, materials, and agriculture that are likely to be positively impacted by the biological innovation trend. To delve deeper into SYNB''s exposure and discover correlations and overlaps, ETF Insider''s web app provides valuable data and visualizations for a comprehensive analysis of this ETF and others in the U.S. market.
ETF Insider is a data-driven portfolio analytics and optimization platform that introduces a more efficient and practical way to visualize, analyze and optimize portfolios.
Rather than focusing on the surface-level attributes of ETFs and Mutual Funds, ETF Insider goes deeper by examining the underlying holdings of exchange traded products.
By organizing and structuring that data, investors can easily navigate within their overlapping layers.
This innovative perspective combined with modern data visualization and modeling tools, provides an entirely new approach to portfolio optimization that can quickly expose both portfolio inefficiencies and opportunities.
5 min readThe BDEC ETF is a specialized investment fund that focuses on global companies in the relevant sectors. This exchange-traded fund offers investors exposure to a diverse range of innovative and cutting-edge companies engaged in advancements in the industry. Discover the potential growth opportunities and risks associated with investing in this dynamic sector through the BDEC ETF.
4 min readEWT VS twi are specialized investment funds that focus on a diverse range of sectors in the financial market. these exchange-traded funds offer investors exposure to various industries and companies, presenting potential growth opportunities and risks. it's essential to understand the underlying assets and strategies of these etfs before considering an investment.
4 min readEWZ is an abbreviation for iShares MSCI Brazil ETF, a widely traded exchange-traded fund that tracks the performance of the MSCI Brazil Index. This ETF is listed on the New York Stock Exchange (NYSE), allowing investors to gain exposure to a diversified basket of Brazilian companies. It provides a convenient way for individuals and institutions to invest in the Brazilian equity market without directly purchasing individual stocks.
ETF Insider is a novel portfolio optimization tool that uses the power of data visualization to gain insight into portfolio compositions, concentration risks, portfolio efficiency and more. Complex financial data can be transformed into visually appealing and easily digestible graphs and charts, allowing investors to quickly identify trends and make well-informed investment decisions. Not only does this save time, but it also increases the accuracy and effectiveness of portfolio management.
